Lenacapavir is a new med from Gilead Sciences. This med is so new I can find next to nothing about it. I see the article I'm referencing & some referring to a previous study over an oral version. This study is suggesting it has the potential to be a single injectable med that could control HIV for up to 6 months.
The article gave limited details on the drug, the study & it's limitations. It appears to be a ways out for now. Still, if it has any potential a bi-annual shot would aid greatly in controlling HIV. The only other piece I could find was a research abstract from the company at $50 a pop.
Will this lead anywhere? I don't know. But, if this research can offer anything, it'd be a boost to fighting HIV. Here's hoping.
Cya...
No comments:
Post a Comment